seed
Stage
2
Investors
About
Fuse Vectors develops a scalable cell-free viral vector manufacturing platform that produces adeno-associated viruses (AAVs) outside of cells, enabling faster, more efficient, and cost-effective gene therapy development.
Explore Fuse Vectors's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.